血管紧张素转换酶基因多态性与终末期肾病
摘要
本文综述了血管张素转换酶基因及其基因多态性与终末期肾病的发生。
出处
《国外医学（泌尿系统分册）》
2004年第4期553-556,共4页
Foreign Medical Sciences(Urology and Nephrology Foreign Medical Sciences)
参考文献20
-
1Hunley TE,Julian BA,Phillips JA,et al.Angiotensin converting enzyme gene polymorphism:potential silencer motif and impact on progression in IgA nephropathy.Kidney Int,1996,49,571～577
-
2Stratta P,Canavese C,Ciccone G,et al.Angiotensin I-converting enzyme genotype significantly affects progression of IgA glomerulonephritis in an Italian population.Am J Kidney Dis,1999,33,1071～1079
-
3Lau YK,Woo KT,Choong HL,et al.ACE gene polymorphism and disease progression of IgA nephropathy in Asians in Singapore.Nephron,2002,91,499～503
-
4Schena FP,D'Altri C,Cerullo G,et al.ACE gene polymorphism and IgA nephropathy:An ethnically homogeneous study and a meta-analysis.Kidney Int,2001,60,732～740
-
5Fava S,Azzopardi J,Ellard S,et al.ACE gene polymorphism as a prognostic indicator in patients with type 2 diabetes and established renal disease.Diabetes Care,2001,24,2115～2120
-
6Gohda T,Makita Y,Shike T,et al.Association of the DD genotype and development of Japanese type 2 diabetic nephropathy.Clin Nephrol,2001,56,475～480
-
7Ha SK,Park HC,Park HS,et al.ACE gene polymorphism and progression of diabetic nephropathy in Korean type 2 diabetic patients:effect of ACE gene DD on the progression of diabetic nephropathy.Am J Kidney Dis,2003,41,943～949
-
8Merta M,Reiterova J,Stekrova J,et al.Influence of the alpha-adducin and ACE gene polymorphism on the progression of autosomal-dominant polycystic kidney disease.Kidney Blood Press Res,2003,26,42～49
-
9Persu A,El-khattabi O,Messiaen T,et al.Influence of ACE(I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease.Nephrol Dial Transplant,2003,18,2032～2038
-
10Konoshita T,Miyagi K,Onoe T,et al.Effect of ACE gene polymorphism on age at renal death in polycystic kidney disease in Japan.Am J Kidney Dis,2001,37,113～118
二级参考文献25
-
1陈朝红,刘志红,王庆文,季曙明,季大玺,黎磊石.血管紧张素转化酶基因多态性在终末期肾功能衰竭患者中的分布及其意义[J].中华肾脏病杂志,1997,13(1):22-24. 被引量：15
-
2Maschio G, Cagnoli L, Claroni F, et al. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study. Nephrol Dial Transplant, 1994, 9:265.
-
3Maruyama K, Yoshida M, Nishio H, et al. Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatr Nephrol,2001,16: 350.
-
4Yoshida H, Mitarai T, Kawamura T, et al. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest, 1995,96:2162.
-
5Hingorani AD, Jia H, Stevens PA, et al.Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibitian.J Hypertens, 1995,13:1602.
-
6Caulfield M, Lavender P, Farrall M, et al.Linkage of the angiotensinogen gene to essential hypertension. New Engl J Med, 1994,330(23):1629.
-
7Bloem IJ,Manatunga A, Tewkesbury DA, et al. The serum angiotensinogen concentration and variants of the angiotensinogen gene in black and white children. J Clin Invest,1995, 95:948.
-
8Mizuiri S, Hemmi H, Kumanimidou H, et al.Angiotensin converting enzyme (ACE) I/D genotype and reval ACE gene expression. Kidney Int 2001, 60:1 124.
-
9Mizuiri S, Yoshikawa H, Tanegashima M, et al. Renal ACE immunohistochemical localization in NIDDM patients with nephropathy.Am J Kidney Dis, 1998, 31:301.
-
10Frimat L,Philippe C,Maghakian M,et al.Polymorphism of angiotensin converting enzyme,angiotensinogen,and angiotensin Ⅱ type 1 receptor genes and end-stage renal failure in IgA nephropathy:IGARAS-a study of 274 men.J Am Soc Nephrol,2000,11:2062
共引文献8
-
1覃学勇.老年慢性肾衰竭103例临床分析[J].右江医学,2004,32(4):346-347.
-
2李良志,牟华明.不同剂量依那普利对原发性肾炎患者血压、血钾的影响[J].中国医院药学杂志,2007,27(9):1268-1269.
-
3尤燕舞,林栩.肾素—血管紧张素系统基因多态性与肾脏疾病的关系[J].右江民族医学院学报,2008,30(3):484-486.
-
4王福诩,卢海庆.慢性肾衰竭并发肾积脓的诊断和治疗[J].当代医学,2009,15(25):51-52. 被引量：8
-
5于丽,田世明,马俐华,田洪臻,宋红霞.脂微球前列腺素E1治疗老年慢性肾功能不全[J].西南国防医药,2013,23(3):260-263. 被引量：2
-
6陆猛桂.狼疮性肾炎免疫抑制治疗新进展[J].内科,2014,9(3):343-345. 被引量：11
-
7刘小艳.苯那普利联合厄贝沙坦治疗小儿慢性肾小球肾炎的临床疗效观察[J].临床肾脏病杂志,2016,16(12):739-743. 被引量：7
-
8王静.慢性肾衰竭并发肾积脓的诊断和治疗[J].中国实用医药,2018,13(16):57-58.
-
1高纯（综述）,夏正（综述）,顾国浩（审校）.血管紧张素转换酶在肾脏疾病中的研究进展[J].国际检验医学杂志,2007,28(1):38-40.
-
2胡伟新,刘志红,唐政,俞雨生,姚小丹,陈朝红,黎磊石.血管紧张素转换酶基因多态性与IgA肾病病情进展的联系[J].解放军医学杂志,1997,22(5):327-329. 被引量：2
-
3薛菲,刘惠兰.糖尿病肾病基因多态性的研究进展[J].国外医学（泌尿系统分册）,2005,25(3):390-395. 被引量：5
-
4郑欣,章友康,李晓雁,朱世乐,白千帆,鄂洁.血管紧张素转换酶基因多态性与IgA肾病的相关性研究[J].中华肾脏病杂志,1999,15(6):379-380. 被引量：3
-
5曾文,路学文.血管紧张素转换酶基因多态性与肾脏疾病[J].河北医药,2000,22(3):227-228.
-
6常凯,衡丙祥.张素梅主任医师治疗肾病蛋白尿的经验[J].中医临床研究,2013,5(20):13-15.
-
7张庆娟,刘殿阁.IgA肾病与局部肾素-血管紧张素系统[J].临床荟萃,2008,23(1):69-71. 被引量：8
-
8杨丽霞,石燕昆,王先梅,齐峰,郭传明,郭瑞威,任丽,李明秋.冠心病患者血管紧张素转化酶基因多态性与血管活性物质的相关性[J].实用医学杂志,2007,23(7):978-980.
-
9廖蕴华,冼苏,罗佐杰.血管紧张素转换酶Ⅰ基因多态性与2型糖尿病肾病的研究[J].医学综述,2002,8(4):233-235. 被引量：1
-
10赵卫红.维生素D基因多态性与慢性肾功能衰竭继发性甲旁亢的关系[J].国际泌尿系统杂志,2003,23(S1):57-59. 被引量：1
